Research Portfolio

Funding Opportunities

Join our Mailing List
Join our mailing list to be notified of new funding opportunities.

Your Email

To receive information about funding opportunities, events, and program updates.

Edward Ball, M.D.

University of California, San Diego # of Grants: 1


Bispecific molecular therapy of small cell lung cancer 2001 (Cycle 10) $434,805
Cancer Research Project Awards

Bombesin/gastrin-releasing peptide receptor: a potential target for antibody-mediated therapy of small cell lung cancer.
Periodical: Clinical Cancer Research Index Medicus:
Authors: Zhou JH, Chen J, Mokotoff M, Zhong RK, Shultz LD, Ball ED ART
Yr: 2003 Vol: 9 Nbr: Abs: Pg: 4953-4960

Caution in the use of 2-iminothiolane (traut's reagent) as a cross-linking agent for peptides. The formation of N-peptidyl-2-iminothiolanes with bombesin (BN) antagonist (D-Trp, Leu 13-psi)
Periodical: Journal of Peptide Research Index Medicus:
Authors: Mokotoff M, Mocarski YM, Gentsch BL, Miller M, Zhou J-H, Chen J, Ball ED ART
Yr: 2001 Vol: 57 Nbr: 5 Abs: Pg: 383-389

Targeting gastrin-releasing peptide receptors for cancer treatment.
Periodical: Anti-cancer Drugs Index Medicus:
Authors: Zhou J-H, Jian Chen J, Mokotoff M, Ball ED ART
Yr: 2004 Vol: 15 Nbr: Abs: Pg: 921-927